Single‐cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer

Documenti analoghi

• Single‐cell and spatial transcriptomics uncover neoadjuvant chemotherapy‐resistant malignant cells with inhibitory signalling on B cells in gastric cancer
  di: Pei‐Yi Han, et al.
  Pubblicazione: (2026)
• Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non‐small‐cell lung cancer
  di: Ke Xu, et al.
  Pubblicazione: (2024)
• In vitro PK/PD modeling of tyrosine kinase inhibitors in non‐small cell lung cancer cell lines
  di: Linda Wanika, et al.
  Pubblicazione: (2024)
• Repotrectinib: Redefining the therapeutic landscape for patients with ROS1 fusion‐driven non‐small cell lung cancer
  di: Antoine Desilets, et al.
  Pubblicazione: (2024)
• Tumour hepcidin levels as a biomarker for predicting response to immune checkpoint inhibition in advanced non‐small cell lung cancer
  di: Yuichiro Suzukawa, et al.
  Pubblicazione: (2026)